dr-mignon-loh-md-104-1440x784-2x
dr-mignon-loh-md-104-320x320-2x

Mignon Loh

MD

Chief of Pediatric Hematology and Oncology
Pediatric hematologist-oncologist
Fan of cooking and hiking

Dr. Mignon Loh, chief of pediatric hematology and oncology, is a cancer specialist who focuses on caring for children with leukemia.

The mission of Loh's research is to bring new laboratory discoveries on pediatric leukemia into the clinic, to ensure that children with the condition receive the most appropriate therapies. Specifically, she investigates better ways to diagnose or treat the disease, as well as ways to predict how an individual patient’s illness will progress.

Loh earned her medical degree at Columbia University. She completed a residency in pediatrics at Boston Children's Hospital and a fellowship in pediatric hematology and oncology at Brigham and Women's Hospital. During her time in Boston, she served as an instructor at Harvard Medical School and as a research fellow at Brigham and Women's Hospital.

For the international research organization Children's Oncology Group, Loh chairs a committee on acute lymphoblastic leukemia (ALL) and is responsible for developing the clinical trial portfolio for newly diagnosed and relapsed patients with the condition. She supervises a highly productive committee and since July 2019 has opened three trials to investigate questions about new immunologic treatments for ALL in children, adolescents and young adults.

  • Education

    Columbia University, 1991

  • Residencies

    Boston Children's Hospital, Pediatrics, 1994

  • Fellowships

    Brigham and Women's Hospital, Pediatric Hematology and Oncology, 1998

Clinics I work with

(2)

oncology-clinic-320x320-2x 3

Oncology Clinic

Oncology Clinic

San Francisco / Oakland / Walnut Creek

oncology-clinic-320x320-2x

Precision Cancer Medicine Program

Precision Cancer Medicine Program

1825 Fourth St., Sixth Floor
San Francisco, CA 94158

Where I see patients (2)

Expand Map

    Decorative Caduceus

    Ponatinib With Chemotherapy in Pediatric Participants With Relapsed, Resistant, or Intolerant P...

    The RP2D is the maximum tolerated dose (MTD) or less.

    Recruiting

    More about this study
    Decorative Caduceus

    A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

    Recruiting

    More about this study
    See all clinical trials

    Tender wagging care

    Our therapy dogs spread joy and smiles at the bedside and throughout the hospital.

    Visit Child Life services

    Share